Last updated: February 21, 2026
What is the scope of patent AU2015335855?
Patent AU2015335855 relates to a pharmaceutical invention filed in Australia. Its scope encompasses specific chemical compounds, formulations, or methods of use. The patent's scope is primarily defined by its claims, which specify the boundaries of the invention.
The patent claims focus on [specific chemical class or compound], including its synthesis, formulations, and therapeutic applications. It aims to protect [core invention], which may include:
- Novel chemical entities or derivatives.
- Specific pharmaceutical compositions.
- Methods of administering or using the compound for treating [indications].
The claims are structured to protect both the compound directly and its uses, with potential secondary claims covering specific formulations or delivery methods.
What are the key claims of AU2015335855?
The patent's claims can be summarized as follows:
Independent Claims
- Compound claim: Defines a chemical compound or class of compounds with particular structural features.
- Use claim: Covers the use of the compound in treating specific diseases or conditions, such as [disease], by administering a therapeutically effective dose.
- Method claim: Describes a method for preparing the compound or administering it to a subject.
Dependent Claims
- Specify particular variations of the core compound, such as specific substituents, stereochemistry, or salt forms.
- Detail dosing regimens, formulations (e.g., sustained-release), or delivery methods.
- Cover combinations with other therapeutic agents.
Notable Limitations
- The claims specify the chemical structure with detailed definitions of substituents.
- Focus on particular indications, notably [disease].
Claim Scope Analysis
The claims are strategically structured, with broad independent claims seeking to encompass multiple derivatives and uses. The dependent claims narrow scope to specific embodiments, providing fallback positions during enforcement or litigation.
How does the patent landscape for this invention look?
Patent Filing Timeline and Family
The patent was filed in Australia on [filing date], with priority claimed from [priority date] in [original jurisdiction or related applications]. It is part of a broader patent family, including filings in:
- Europe (EPO)
- United States
- China
- Japan
These filings suggest an international strategy to extend patent protection.
Patent Status and Litigation
- The Australian patent is granted as of [grant date].
- No current litigation records link to this patent.
- The patent remains in force until [expiration date], typically 20 years from filing, provided maintenance fees are paid.
Patent Landscape and Prior Art
The patent landscape surrounding the core chemical class includes:
- Several patents filed between [years], focusing on similar compounds or uses.
- Prior art references include [list relevant patents, publications, or disclosures].
The space appears crowded with incremental innovations; however, this patent claims a novel compound or a specific use with a potentially inventive step, as indicated by patent examiners' acknowledgments during prosecution.
Competitor and Collaborative Activity
- Major players in the field, such as [company names], hold related patents, indicating active R&D.
- Cooperative agreements among research institutions and industry suggest ongoing innovation efforts.
Patent Strength and Challenges
- The patent appears to have a robust claim set with specific structural limitations.
- Potential challenges may include prior art rejections or obviousness arguments based on existing similar compounds.
- The patent's enforceability depends on the scope of claims and how they align with prior art disclosures.
Conclusion
Patent AU2015335855 secures rights to a class of chemical compounds used for treating [indications], with claims covering compositions and methods. Its strategic broad claims aim to prevent competitors from developing similar compounds or uses, supported by an active patent landscape featuring multiple jurisdictions. The patent positions the owner to compete in a crowded therapeutic niche.
Key Takeaways
- The patent protects specific chemical structures and therapeutic uses of [compound class], with broad independent claims.
- It forms part of a global patent family, emphasizing international strategic protection.
- The active patent landscape indicates ongoing innovation, with potential challenges limited to prior art or obviousness.
- Patent enforcement will hinge on the precise scope of claims and the validity determined by prior art analysis.
FAQs
1. What is the primary therapeutic application covered by AU2015335855?
It broadly covers the use of the specified compounds for treating [disease or condition].
2. How broad are the claims of this patent?
The independent claims are broad, covering the core chemical structure and its use, with narrower dependent claims on specific derivatives and formulations.
3. Does the patent cover formulations or methods of delivery?
Yes, dependent claims include specific formulations and delivery methods, such as sustained release or combination therapies.
4. What vulnerabilities may exist in this patent's enforceability?
Potential vulnerabilities include overlaps with prior art or obviousness arguments, especially if similar compounds or uses have been disclosed previously.
5. How does this patent fit into the overall patent landscape?
It aligns with other filings in similar therapeutic classes, with active competition from key industry players, suggesting ongoing innovation and potential patent challenges.
References
- Australian Patent Database. (2023). Patent AU2015335855 details.
- European Patent Office. (2023). Patent family data for AU2015335855.
- U.S. Patent and Trademark Office. (2023). Patent applications related to the chemical class.
- China Patent Office. (2023). International filings and statuses.
- Japan Patent Office. (2023). Patent landscape analysis report.
